| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Vulvar Lichen Sclerosus | 5 | 2022 | 11 | 2.870 |
Why?
|
| Vagina | 16 | 2023 | 825 | 2.570 |
Why?
|
| Mullerian Ducts | 10 | 2023 | 198 | 2.250 |
Why?
|
| Menorrhagia | 9 | 2022 | 63 | 2.240 |
Why?
|
| Developmental Disabilities | 9 | 2021 | 1452 | 2.000 |
Why?
|
| Gynecologic Surgical Procedures | 12 | 2022 | 337 | 1.810 |
Why?
|
| Menstruation Disturbances | 7 | 2015 | 148 | 1.770 |
Why?
|
| Ovarian Diseases | 3 | 2023 | 139 | 1.710 |
Why?
|
| Menstruation | 8 | 2023 | 302 | 1.600 |
Why?
|
| Uterus | 8 | 2023 | 711 | 1.580 |
Why?
|
| Lichen Sclerosus et Atrophicus | 2 | 2022 | 28 | 1.540 |
Why?
|
| Vulvar Diseases | 4 | 2017 | 61 | 1.480 |
Why?
|
| Uterine Hemorrhage | 4 | 2023 | 255 | 1.460 |
Why?
|
| Congenital Abnormalities | 9 | 2023 | 707 | 1.290 |
Why?
|
| Gynecology | 7 | 2021 | 512 | 1.280 |
Why?
|
| Spinal Dysraphism | 5 | 2020 | 161 | 1.250 |
Why?
|
| Genitalia, Female | 3 | 2017 | 146 | 1.220 |
Why?
|
| Torsion Abnormality | 3 | 2023 | 93 | 1.190 |
Why?
|
| Menarche | 5 | 2023 | 516 | 1.170 |
Why?
|
| Disabled Persons | 8 | 2023 | 1214 | 1.150 |
Why?
|
| Hymen | 3 | 2014 | 16 | 1.140 |
Why?
|
| 46, XX Disorders of Sex Development | 5 | 2023 | 31 | 1.110 |
Why?
|
| Sex Education | 4 | 2020 | 93 | 1.090 |
Why?
|
| Genital Diseases, Female | 2 | 2019 | 197 | 1.060 |
Why?
|
| Urogenital Abnormalities | 3 | 2014 | 261 | 1.020 |
Why?
|
| Cysts | 4 | 2023 | 678 | 0.990 |
Why?
|
| Endometriosis | 5 | 2014 | 838 | 0.940 |
Why?
|
| Progestins | 2 | 2023 | 306 | 0.890 |
Why?
|
| Adolescent | 67 | 2023 | 85729 | 0.780 |
Why?
|
| Vulvovaginitis | 1 | 2020 | 16 | 0.770 |
Why?
|
| Menstrual Cycle | 5 | 2016 | 551 | 0.720 |
Why?
|
| Ovarian Cysts | 1 | 2020 | 115 | 0.710 |
Why?
|
| Angiokeratoma | 1 | 2019 | 5 | 0.700 |
Why?
|
| Reproductive Health Services | 3 | 2020 | 80 | 0.680 |
Why?
|
| Polycystic Ovary Syndrome | 2 | 2019 | 370 | 0.670 |
Why?
|
| Ovarian Neoplasms | 3 | 2023 | 4839 | 0.660 |
Why?
|
| Endometrial Hyperplasia | 1 | 2019 | 97 | 0.640 |
Why?
|
| Ovariectomy | 1 | 2020 | 661 | 0.620 |
Why?
|
| Dysmenorrhea | 3 | 2020 | 86 | 0.620 |
Why?
|
| Endometrial Neoplasms | 2 | 2019 | 1350 | 0.600 |
Why?
|
| Dyspareunia | 2 | 2014 | 50 | 0.600 |
Why?
|
| Breast Cyst | 1 | 2017 | 8 | 0.600 |
Why?
|
| Vulvar Neoplasms | 3 | 2011 | 272 | 0.590 |
Why?
|
| Laparoscopy | 7 | 2022 | 2148 | 0.570 |
Why?
|
| Female | 99 | 2023 | 380020 | 0.570 |
Why?
|
| Personal Satisfaction | 1 | 2021 | 641 | 0.560 |
Why?
|
| Adolescent Development | 2 | 2017 | 279 | 0.560 |
Why?
|
| Mosaicism | 3 | 2015 | 441 | 0.550 |
Why?
|
| Abnormalities, Multiple | 3 | 2013 | 1416 | 0.530 |
Why?
|
| Hypothyroidism | 1 | 2020 | 659 | 0.520 |
Why?
|
| Puberty | 3 | 2014 | 490 | 0.520 |
Why?
|
| Gonadal Dysgenesis, 46,XY | 1 | 2014 | 11 | 0.510 |
Why?
|
| Gonadoblastoma | 1 | 2014 | 14 | 0.510 |
Why?
|
| Breast | 4 | 2017 | 1970 | 0.510 |
Why?
|
| Sexual Behavior | 7 | 2022 | 2049 | 0.500 |
Why?
|
| Sclerotherapy | 1 | 2016 | 175 | 0.500 |
Why?
|
| Confidentiality | 2 | 2020 | 613 | 0.490 |
Why?
|
| Lymphatic Abnormalities | 1 | 2016 | 133 | 0.480 |
Why?
|
| Tissue Adhesions | 2 | 2015 | 235 | 0.480 |
Why?
|
| Parental Consent | 1 | 2014 | 62 | 0.480 |
Why?
|
| Contraceptives, Oral, Hormonal | 4 | 2020 | 188 | 0.480 |
Why?
|
| Sterilization, Reproductive | 2 | 2011 | 21 | 0.460 |
Why?
|
| Mouth Mucosa | 2 | 2014 | 432 | 0.460 |
Why?
|
| CA-125 Antigen | 2 | 2021 | 286 | 0.460 |
Why?
|
| Constriction, Pathologic | 1 | 2017 | 1108 | 0.450 |
Why?
|
| Third-Party Consent | 2 | 2011 | 64 | 0.450 |
Why?
|
| Child | 30 | 2023 | 77637 | 0.440 |
Why?
|
| Cervix Uteri | 3 | 2017 | 590 | 0.440 |
Why?
|
| Gynecological Examination | 3 | 2020 | 33 | 0.430 |
Why?
|
| Minors | 1 | 2011 | 50 | 0.380 |
Why?
|
| Humans | 100 | 2023 | 743811 | 0.380 |
Why?
|
| Retrospective Studies | 25 | 2023 | 77410 | 0.370 |
Why?
|
| Educational Measurement | 1 | 2017 | 1210 | 0.370 |
Why?
|
| Vascular Malformations | 1 | 2016 | 454 | 0.370 |
Why?
|
| Premenstrual Syndrome | 2 | 2015 | 109 | 0.360 |
Why?
|
| Uterine Diseases | 2 | 2013 | 135 | 0.360 |
Why?
|
| Health Knowledge, Attitudes, Practice | 5 | 2023 | 3921 | 0.360 |
Why?
|
| Attitude of Health Personnel | 4 | 2019 | 3839 | 0.350 |
Why?
|
| Self Concept | 2 | 2006 | 1024 | 0.340 |
Why?
|
| Caregivers | 1 | 2021 | 2098 | 0.340 |
Why?
|
| Pelvic Pain | 4 | 2017 | 274 | 0.330 |
Why?
|
| Glucocorticoids | 2 | 2019 | 2107 | 0.320 |
Why?
|
| Michigan | 4 | 2020 | 350 | 0.320 |
Why?
|
| Vaginal Smears | 2 | 2009 | 511 | 0.320 |
Why?
|
| Testicular Neoplasms | 1 | 2014 | 803 | 0.310 |
Why?
|
| Sexual Dysfunction, Physiological | 2 | 2022 | 355 | 0.310 |
Why?
|
| Amenorrhea | 2 | 2014 | 485 | 0.300 |
Why?
|
| Emergency Service, Hospital | 4 | 2023 | 7658 | 0.300 |
Why?
|
| Ulcer | 1 | 2008 | 209 | 0.300 |
Why?
|
| Women's Health | 4 | 2020 | 2033 | 0.300 |
Why?
|
| Cytological Techniques | 1 | 2009 | 219 | 0.290 |
Why?
|
| Cerebral Palsy | 2 | 2009 | 459 | 0.290 |
Why?
|
| Dermatitis | 1 | 2008 | 199 | 0.290 |
Why?
|
| Child, Preschool | 12 | 2023 | 40964 | 0.280 |
Why?
|
| Neurofibromatosis 1 | 1 | 2011 | 570 | 0.270 |
Why?
|
| Administration, Topical | 3 | 2019 | 689 | 0.260 |
Why?
|
| Estrogens | 3 | 2023 | 1563 | 0.260 |
Why?
|
| Myometrium | 1 | 2006 | 181 | 0.260 |
Why?
|
| Young Adult | 26 | 2022 | 56392 | 0.260 |
Why?
|
| Medroxyprogesterone Acetate | 1 | 2006 | 163 | 0.260 |
Why?
|
| Sexually Transmitted Diseases, Viral | 1 | 2005 | 40 | 0.250 |
Why?
|
| Child Abuse, Sexual | 2 | 2020 | 383 | 0.250 |
Why?
|
| Uterine Cervical Dysplasia | 1 | 2009 | 387 | 0.250 |
Why?
|
| Contraceptives, Oral, Combined | 3 | 2020 | 113 | 0.250 |
Why?
|
| Condylomata Acuminata | 1 | 2005 | 82 | 0.250 |
Why?
|
| Health Promotion | 1 | 2017 | 2205 | 0.250 |
Why?
|
| Contraception | 3 | 2022 | 359 | 0.240 |
Why?
|
| Pain | 4 | 2022 | 4987 | 0.240 |
Why?
|
| Hematocolpos | 1 | 2003 | 6 | 0.230 |
Why?
|
| Hemorrhagic Disorders | 2 | 2021 | 36 | 0.230 |
Why?
|
| Uterine Cervical Neoplasms | 2 | 2021 | 2018 | 0.220 |
Why?
|
| Vulva | 2 | 2022 | 87 | 0.220 |
Why?
|
| Adolescent Medicine | 1 | 2003 | 72 | 0.220 |
Why?
|
| Turner Syndrome | 1 | 2003 | 130 | 0.210 |
Why?
|
| Hysterectomy | 3 | 2021 | 927 | 0.210 |
Why?
|
| Hydrocolpos | 1 | 2022 | 2 | 0.210 |
Why?
|
| Hygiene | 2 | 2016 | 97 | 0.210 |
Why?
|
| Depression | 3 | 2021 | 7760 | 0.210 |
Why?
|
| Vaginal Diseases | 1 | 2003 | 102 | 0.210 |
Why?
|
| Muscle Spasticity | 1 | 2003 | 154 | 0.210 |
Why?
|
| Pelvic Floor | 1 | 2003 | 138 | 0.200 |
Why?
|
| Adnexa Uteri | 1 | 2021 | 45 | 0.200 |
Why?
|
| Diagnosis, Differential | 7 | 2019 | 12954 | 0.200 |
Why?
|
| Down Syndrome | 1 | 2009 | 880 | 0.190 |
Why?
|
| Counseling | 3 | 2021 | 1523 | 0.190 |
Why?
|
| Anxiety | 3 | 2021 | 4288 | 0.190 |
Why?
|
| Parents | 4 | 2020 | 3403 | 0.190 |
Why?
|
| Levonorgestrel | 1 | 2021 | 77 | 0.190 |
Why?
|
| Medical History Taking | 2 | 2014 | 782 | 0.190 |
Why?
|
| Lacerations | 1 | 2022 | 143 | 0.180 |
Why?
|
| Immunosuppressive Agents | 1 | 2013 | 4152 | 0.180 |
Why?
|
| Poliomyelitis | 3 | 2006 | 103 | 0.180 |
Why?
|
| Hospitalization | 1 | 2019 | 10259 | 0.180 |
Why?
|
| Adult | 32 | 2023 | 213889 | 0.180 |
Why?
|
| Physicians | 2 | 2017 | 4569 | 0.180 |
Why?
|
| Autistic Disorder | 1 | 2009 | 1162 | 0.180 |
Why?
|
| Contraceptive Agents, Female | 2 | 2014 | 135 | 0.180 |
Why?
|
| Syndrome | 2 | 2020 | 3249 | 0.180 |
Why?
|
| Ointments | 1 | 2019 | 59 | 0.170 |
Why?
|
| Skin Neoplasms | 1 | 2019 | 5691 | 0.170 |
Why?
|
| Clobetasol | 1 | 2019 | 34 | 0.170 |
Why?
|
| Job Satisfaction | 2 | 2015 | 535 | 0.170 |
Why?
|
| Hemochromatosis | 1 | 2020 | 184 | 0.170 |
Why?
|
| Triamcinolone | 1 | 2019 | 68 | 0.170 |
Why?
|
| Hormone Replacement Therapy | 2 | 2020 | 708 | 0.170 |
Why?
|
| von Willebrand Diseases | 1 | 2020 | 127 | 0.170 |
Why?
|
| Pelvic Organ Prolapse | 1 | 2021 | 136 | 0.160 |
Why?
|
| Clinical Competence | 1 | 2014 | 4687 | 0.160 |
Why?
|
| Papillomaviridae | 1 | 2005 | 1119 | 0.160 |
Why?
|
| Menopause | 4 | 2023 | 1626 | 0.160 |
Why?
|
| Urologic Diseases | 1 | 2021 | 243 | 0.160 |
Why?
|
| Case-Control Studies | 3 | 2023 | 21733 | 0.160 |
Why?
|
| Mammaplasty | 2 | 2009 | 1204 | 0.160 |
Why?
|
| Fecal Incontinence | 1 | 2021 | 239 | 0.160 |
Why?
|
| Antifibrinolytic Agents | 1 | 2020 | 254 | 0.150 |
Why?
|
| Gonadal Dysgenesis | 1 | 2017 | 30 | 0.150 |
Why?
|
| Psychosexual Development | 1 | 2017 | 20 | 0.150 |
Why?
|
| MAP Kinase Kinase Kinase 1 | 1 | 2017 | 58 | 0.150 |
Why?
|
| Sex Differentiation | 1 | 2017 | 73 | 0.150 |
Why?
|
| Neoplasm Recurrence, Local | 2 | 2016 | 9239 | 0.150 |
Why?
|
| Internship and Residency | 1 | 2017 | 5787 | 0.150 |
Why?
|
| Obesity | 1 | 2019 | 12744 | 0.140 |
Why?
|
| Blood Coagulation Disorders | 1 | 2019 | 337 | 0.140 |
Why?
|
| Professional-Family Relations | 1 | 2020 | 482 | 0.140 |
Why?
|
| Abdominal Pain | 2 | 2018 | 1064 | 0.140 |
Why?
|
| Obstetric Labor Complications | 1 | 2018 | 238 | 0.140 |
Why?
|
| Thyroid Diseases | 1 | 2019 | 379 | 0.130 |
Why?
|
| Nausea | 1 | 2018 | 674 | 0.130 |
Why?
|
| Sex Chromosome Aberrations | 1 | 2015 | 114 | 0.130 |
Why?
|
| Pregnancy | 8 | 2022 | 29140 | 0.130 |
Why?
|
| Vomiting | 1 | 2018 | 636 | 0.130 |
Why?
|
| Anemia | 2 | 2022 | 1502 | 0.130 |
Why?
|
| Virilism | 1 | 2014 | 31 | 0.130 |
Why?
|
| Mass Screening | 2 | 2021 | 5251 | 0.130 |
Why?
|
| Surgically-Created Structures | 1 | 2014 | 10 | 0.130 |
Why?
|
| Life Style | 1 | 2006 | 3833 | 0.130 |
Why?
|
| Disorders of Sex Development | 1 | 2015 | 122 | 0.120 |
Why?
|
| Chromosomes, Human, Y | 1 | 2015 | 147 | 0.120 |
Why?
|
| Faculty, Medical | 2 | 2015 | 1181 | 0.120 |
Why?
|
| Magnetic Resonance Imaging | 7 | 2020 | 35409 | 0.120 |
Why?
|
| Self Disclosure | 1 | 2015 | 251 | 0.120 |
Why?
|
| Doxycycline | 1 | 2016 | 326 | 0.120 |
Why?
|
| Asthma | 1 | 2013 | 6010 | 0.120 |
Why?
|
| Chromosomes, Human, X | 1 | 2015 | 296 | 0.120 |
Why?
|
| Self Efficacy | 2 | 2015 | 615 | 0.120 |
Why?
|
| Qualitative Research | 5 | 2022 | 2682 | 0.120 |
Why?
|
| Angelman Syndrome | 1 | 2015 | 136 | 0.120 |
Why?
|
| Steroids | 1 | 2019 | 930 | 0.120 |
Why?
|
| Endosonography | 1 | 2017 | 610 | 0.120 |
Why?
|
| Ultrasonography | 2 | 2023 | 5986 | 0.120 |
Why?
|
| Vulvodynia | 1 | 2013 | 9 | 0.110 |
Why?
|
| Pelvis | 1 | 2017 | 730 | 0.110 |
Why?
|
| Elasticity Imaging Techniques | 1 | 2018 | 388 | 0.110 |
Why?
|
| Dilatation | 1 | 2014 | 291 | 0.110 |
Why?
|
| Pregnancy, Ectopic | 1 | 2014 | 141 | 0.110 |
Why?
|
| Career Mobility | 1 | 2015 | 262 | 0.110 |
Why?
|
| Cystitis, Interstitial | 1 | 2013 | 61 | 0.110 |
Why?
|
| Thrombosis | 2 | 2022 | 2968 | 0.110 |
Why?
|
| Quality of Life | 5 | 2023 | 12788 | 0.110 |
Why?
|
| Sexual Maturation | 1 | 2014 | 265 | 0.110 |
Why?
|
| Leiomyoma | 1 | 2018 | 730 | 0.110 |
Why?
|
| Pregnancy Complications | 2 | 2018 | 2861 | 0.110 |
Why?
|
| Mental Health | 1 | 2006 | 3012 | 0.110 |
Why?
|
| Physical Examination | 2 | 2009 | 1235 | 0.100 |
Why?
|
| Genital Neoplasms, Female | 1 | 2017 | 523 | 0.100 |
Why?
|
| Hospitals, Pediatric | 1 | 2020 | 1775 | 0.100 |
Why?
|
| Fatigue Syndrome, Chronic | 1 | 2013 | 213 | 0.100 |
Why?
|
| Referral and Consultation | 2 | 2021 | 3530 | 0.090 |
Why?
|
| Peer Group | 1 | 2015 | 635 | 0.090 |
Why?
|
| Medical Staff | 1 | 2010 | 43 | 0.090 |
Why?
|
| Patient Preference | 1 | 2017 | 889 | 0.090 |
Why?
|
| Temporomandibular Joint Disorders | 1 | 2013 | 215 | 0.090 |
Why?
|
| Delayed Diagnosis | 1 | 2013 | 441 | 0.090 |
Why?
|
| Cross-Sectional Studies | 9 | 2023 | 25032 | 0.090 |
Why?
|
| Cohort Studies | 3 | 2022 | 40545 | 0.090 |
Why?
|
| Venous Thromboembolism | 1 | 2022 | 1670 | 0.090 |
Why?
|
| Paraplegia | 1 | 2010 | 169 | 0.090 |
Why?
|
| Physicians, Women | 1 | 2015 | 486 | 0.080 |
Why?
|
| Androgen-Insensitivity Syndrome | 1 | 2008 | 31 | 0.080 |
Why?
|
| Norethindrone | 2 | 2006 | 59 | 0.080 |
Why?
|
| Obstetrics and Gynecology Department, Hospital | 1 | 2009 | 43 | 0.080 |
Why?
|
| Sexuality | 2 | 2022 | 172 | 0.080 |
Why?
|
| Uterine Neoplasms | 1 | 2018 | 1513 | 0.080 |
Why?
|
| Fibromyalgia | 1 | 2013 | 388 | 0.080 |
Why?
|
| Ferritins | 2 | 2022 | 590 | 0.080 |
Why?
|
| Tissue Expansion Devices | 1 | 2009 | 156 | 0.080 |
Why?
|
| Quadriplegia | 1 | 2010 | 223 | 0.080 |
Why?
|
| Family | 1 | 2019 | 3144 | 0.080 |
Why?
|
| Infertility, Female | 1 | 2014 | 788 | 0.080 |
Why?
|
| Interpersonal Relations | 1 | 2015 | 1424 | 0.080 |
Why?
|
| Body Mass Index | 4 | 2019 | 12718 | 0.080 |
Why?
|
| Depressive Disorder | 1 | 2021 | 3744 | 0.080 |
Why?
|
| Irritable Bowel Syndrome | 1 | 2013 | 445 | 0.070 |
Why?
|
| Iliac Artery | 1 | 2009 | 364 | 0.070 |
Why?
|
| Social Support | 1 | 2017 | 2118 | 0.070 |
Why?
|
| Medicine | 1 | 2015 | 945 | 0.070 |
Why?
|
| Prevalence | 2 | 2014 | 15211 | 0.070 |
Why?
|
| Hospitals, University | 1 | 2009 | 570 | 0.070 |
Why?
|
| Anti-Inflammatory Agents, Non-Steroidal | 2 | 2009 | 2281 | 0.070 |
Why?
|
| Hormone Antagonists | 1 | 2006 | 108 | 0.070 |
Why?
|
| Male | 14 | 2020 | 349776 | 0.070 |
Why?
|
| Surgical Instruments | 1 | 2009 | 395 | 0.070 |
Why?
|
| Contraceptives, Oral, Synthetic | 1 | 2005 | 16 | 0.070 |
Why?
|
| Coitus | 1 | 2006 | 132 | 0.070 |
Why?
|
| Infant, Newborn | 4 | 2022 | 25609 | 0.070 |
Why?
|
| Physician-Patient Relations | 1 | 2019 | 3229 | 0.070 |
Why?
|
| Breast Implants | 1 | 2009 | 387 | 0.070 |
Why?
|
| Treatment Outcome | 5 | 2023 | 63042 | 0.060 |
Why?
|
| Hormones | 2 | 2022 | 889 | 0.060 |
Why?
|
| Headache | 1 | 2013 | 1224 | 0.060 |
Why?
|
| Recurrence | 2 | 2015 | 8337 | 0.060 |
Why?
|
| Necrosis | 1 | 2009 | 1642 | 0.060 |
Why?
|
| Biopsy | 2 | 2008 | 6750 | 0.060 |
Why?
|
| Urethra | 2 | 2022 | 407 | 0.060 |
Why?
|
| Low Back Pain | 1 | 2013 | 956 | 0.060 |
Why?
|
| Metaphase | 1 | 2003 | 151 | 0.060 |
Why?
|
| Cognition Disorders | 2 | 2015 | 4041 | 0.060 |
Why?
|
| Postoperative Care | 1 | 2010 | 1485 | 0.060 |
Why?
|
| Hirsutism | 1 | 2002 | 69 | 0.050 |
Why?
|
| Gonadotropins | 1 | 2003 | 240 | 0.050 |
Why?
|
| Teaching | 1 | 2010 | 1173 | 0.050 |
Why?
|
| Time Factors | 2 | 2020 | 40038 | 0.050 |
Why?
|
| Wounds, Nonpenetrating | 1 | 2009 | 795 | 0.050 |
Why?
|
| Intracranial Arteriovenous Malformations | 1 | 2005 | 356 | 0.050 |
Why?
|
| Infant | 4 | 2018 | 35122 | 0.050 |
Why?
|
| Spinal Cord Injuries | 1 | 2010 | 931 | 0.050 |
Why?
|
| Rectum | 2 | 2022 | 904 | 0.050 |
Why?
|
| Cloaca | 1 | 2022 | 52 | 0.050 |
Why?
|
| United States | 6 | 2021 | 69859 | 0.050 |
Why?
|
| Thrombasthenia | 1 | 2020 | 24 | 0.050 |
Why?
|
| Orgasm | 1 | 2020 | 61 | 0.050 |
Why?
|
| Medical Errors | 1 | 2009 | 1297 | 0.050 |
Why?
|
| Middle Aged | 13 | 2020 | 213241 | 0.040 |
Why?
|
| Hair | 1 | 2003 | 480 | 0.040 |
Why?
|
| Urination Disorders | 1 | 2021 | 241 | 0.040 |
Why?
|
| Bone Development | 1 | 2003 | 483 | 0.040 |
Why?
|
| HIV Seropositivity | 1 | 2005 | 971 | 0.040 |
Why?
|
| Urinary Incontinence | 1 | 2003 | 496 | 0.040 |
Why?
|
| Chronic Disease | 1 | 2013 | 9139 | 0.040 |
Why?
|
| Comorbidity | 1 | 2013 | 10380 | 0.040 |
Why?
|
| Pregnancy, Unplanned | 1 | 2019 | 95 | 0.040 |
Why?
|
| Abscess | 1 | 2022 | 607 | 0.040 |
Why?
|
| Fear | 2 | 2017 | 1438 | 0.040 |
Why?
|
| Psychometrics | 2 | 2023 | 3000 | 0.040 |
Why?
|
| Sexual Partners | 1 | 2022 | 728 | 0.040 |
Why?
|
| Kidney | 1 | 2013 | 7185 | 0.040 |
Why?
|
| Women | 1 | 2019 | 230 | 0.040 |
Why?
|
| Body Height | 1 | 2003 | 1579 | 0.040 |
Why?
|
| Risk Factors | 3 | 2022 | 72252 | 0.040 |
Why?
|
| Hematoma | 1 | 2022 | 758 | 0.040 |
Why?
|
| Chromosome Aberrations | 1 | 2003 | 1811 | 0.040 |
Why?
|
| Gonadal Steroid Hormones | 1 | 2021 | 710 | 0.040 |
Why?
|
| Constipation | 1 | 2021 | 546 | 0.030 |
Why?
|
| Internal-External Control | 1 | 2017 | 363 | 0.030 |
Why?
|
| Smoking | 1 | 2013 | 8984 | 0.030 |
Why?
|
| Prospective Studies | 5 | 2020 | 53250 | 0.030 |
Why?
|
| Metformin | 1 | 2002 | 837 | 0.030 |
Why?
|
| Reproducibility of Results | 3 | 2023 | 19894 | 0.030 |
Why?
|
| Postmenopause | 1 | 2004 | 2458 | 0.030 |
Why?
|
| Focus Groups | 1 | 2020 | 1320 | 0.030 |
Why?
|
| Leg | 1 | 2020 | 1116 | 0.030 |
Why?
|
| Causality | 1 | 2021 | 1275 | 0.030 |
Why?
|
| Sex Offenses | 1 | 2019 | 354 | 0.030 |
Why?
|
| Urinary Tract Infections | 1 | 2021 | 788 | 0.030 |
Why?
|
| Treatment Failure | 1 | 2020 | 2617 | 0.030 |
Why?
|
| Intrauterine Devices | 1 | 2015 | 122 | 0.030 |
Why?
|
| Contraceptive Agents | 1 | 2015 | 151 | 0.030 |
Why?
|
| Twins | 1 | 2015 | 339 | 0.030 |
Why?
|
| Survivors | 1 | 2004 | 2291 | 0.030 |
Why?
|
| Age Distribution | 1 | 2020 | 2899 | 0.030 |
Why?
|
| Body Composition | 1 | 2003 | 2401 | 0.030 |
Why?
|
| Iron | 1 | 2022 | 1774 | 0.030 |
Why?
|
| Prognosis | 1 | 2013 | 29052 | 0.030 |
Why?
|
| Health Education | 1 | 2019 | 1056 | 0.030 |
Why?
|
| Trust | 1 | 2015 | 505 | 0.020 |
Why?
|
| Interprofessional Relations | 1 | 2017 | 1009 | 0.020 |
Why?
|
| Endometrium | 1 | 2013 | 423 | 0.020 |
Why?
|
| Hypoglycemic Agents | 1 | 2002 | 2877 | 0.020 |
Why?
|
| Neoplasm Staging | 1 | 2005 | 11036 | 0.020 |
Why?
|
| Health Care Surveys | 1 | 2017 | 2453 | 0.020 |
Why?
|
| Pedigree | 1 | 2017 | 4643 | 0.020 |
Why?
|
| Ambulatory Care | 1 | 2020 | 2707 | 0.020 |
Why?
|
| Tissue Transplantation | 1 | 2009 | 129 | 0.020 |
Why?
|
| Mothers | 1 | 2019 | 2166 | 0.020 |
Why?
|
| Melanoma | 1 | 2006 | 5508 | 0.020 |
Why?
|
| Early Detection of Cancer | 1 | 2021 | 3089 | 0.020 |
Why?
|
| Anticoagulants | 1 | 2022 | 4599 | 0.020 |
Why?
|
| Medicaid | 1 | 2020 | 2736 | 0.020 |
Why?
|
| Anal Canal | 1 | 2009 | 376 | 0.020 |
Why?
|
| Databases, Factual | 1 | 2021 | 7729 | 0.020 |
Why?
|
| Analgesics | 1 | 2013 | 1040 | 0.020 |
Why?
|
| Logistic Models | 2 | 2015 | 13404 | 0.020 |
Why?
|
| Patient Care Team | 1 | 2017 | 2528 | 0.020 |
Why?
|
| Mentors | 1 | 2010 | 631 | 0.020 |
Why?
|
| Pilot Projects | 1 | 2018 | 8316 | 0.020 |
Why?
|
| Phenytoin | 1 | 2005 | 197 | 0.020 |
Why?
|
| Severity of Illness Index | 2 | 2017 | 15526 | 0.020 |
Why?
|
| Aged | 4 | 2009 | 163178 | 0.010 |
Why?
|
| Hypertension | 1 | 2002 | 8480 | 0.010 |
Why?
|
| Factor Analysis, Statistical | 1 | 2005 | 975 | 0.010 |
Why?
|
| Communication | 1 | 2015 | 3748 | 0.010 |
Why?
|
| Sex Factors | 1 | 2015 | 10394 | 0.010 |
Why?
|
| Robotics | 1 | 2009 | 899 | 0.010 |
Why?
|
| Incidence | 1 | 2019 | 20948 | 0.010 |
Why?
|
| Drug Interactions | 1 | 2005 | 1460 | 0.010 |
Why?
|
| Linear Models | 1 | 2010 | 5952 | 0.010 |
Why?
|
| Academic Medical Centers | 1 | 2010 | 2760 | 0.010 |
Why?
|
| Estrogen Replacement Therapy | 1 | 2006 | 1203 | 0.010 |
Why?
|
| Cholesterol, HDL | 1 | 2004 | 1813 | 0.010 |
Why?
|
| Social Class | 1 | 2006 | 1997 | 0.010 |
Why?
|
| Activities of Daily Living | 1 | 2006 | 2419 | 0.010 |
Why?
|
| Patient Satisfaction | 1 | 2009 | 3391 | 0.010 |
Why?
|
| Anticonvulsants | 1 | 2005 | 1910 | 0.010 |
Why?
|
| Cholesterol, LDL | 1 | 2004 | 2354 | 0.010 |
Why?
|
| Cerebral Hemorrhage | 1 | 2005 | 2647 | 0.010 |
Why?
|
| Age Factors | 1 | 2010 | 18355 | 0.010 |
Why?
|
| Health Behavior | 1 | 2004 | 2634 | 0.010 |
Why?
|
| Mutation | 1 | 2017 | 29777 | 0.010 |
Why?
|
| Sensitivity and Specificity | 1 | 2007 | 14714 | 0.010 |
Why?
|
| Health Status | 1 | 2004 | 4031 | 0.010 |
Why?
|
| Socioeconomic Factors | 1 | 2004 | 7784 | 0.010 |
Why?
|
| Animals | 1 | 2022 | 168660 | 0.010 |
Why?
|
| Aged, 80 and over | 1 | 2006 | 57744 | 0.000 |
Why?
|